ArticleJournal of the Chinese Medical Association : JCMA2026
Acute radiation dermatitis during head-and-neck radiotherapy: VMAT vs IMPT.
Article in Journal of the Chinese Medical Association : JCMA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute radiation dermatitis (ARD) is common during head-and-neck radiotherapy (RT) and may impair skin-related quality of life (QoL). Whether intensity-modulated proton therapy (IMPT) improves patient-reported skin outcomes compared with volumetric modulated arc therapy (VMAT) remains uncertain. We compared longitudinal outcomes of skin toxicity between RT modalities and identified significant predictors of ARD and skin-related QoL.
methodsThis prospective and nonrandomized cohort study enrolled adults with newly diagnosed head-and-neck cancer receiving curative-intent VMAT or IMPT at Kaohsiung Chang Gung Memorial Hospital. Skin-related QoL was assessed using Skindex-16 at baseline, end of RT, and 3 months after RT. ARD was graded weekly using Common Terminology Criteria for Adverse Events version 5.0. Longitudinal outcomes were analyzed using linear mixed-effects models, and predictors of ARD grade ≥2 and ≥10-point worsening in Skindex-16 Global score were evaluated using multivariable regression.
resultsAmong 158 patients, 113 received VMAT and 45 received IMPT; the mean age was 56.5 years, and 130 patients (82.3%) were men. Clinically meaningful Global score worsening occurred in 37.0% of patients at the end of RT and 7.0% at 3 months after RT. Skindex-16 scores worsened significantly at the end of RT and improved by 3 months across all domains (all p < 0.01), with no significant difference between VMAT and IMPT or time-by-modality interactions. Maximum ARD severity was comparable between VMAT and IMPT (grade 2: 30.0% vs 29.5%; grade 3: 7.0% vs 4.8%; p = 0.85). Advanced nodal disease (N2-3) and RT dose ≥66 Gy independently predicted ARD grade ≥2 and Skindex-16 Global score worsening.
conclusionAcute patient-reported skin toxicity during contemporary head-and-neck RT was not associated with RT modality but with nodal extent and RT dose. These findings support risk-adapted planning and proactive supportive care, although interpretation is limited by the nonrandomized design and lack ofskin-specific dosimetry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.